NASDAQ$RXST
Rxsight Inc · Q4 2022 earnings
Q4 2022 earnings · · Investor relations
Briefing
RxSight's Q4 2022 earnings were reported, showing significant revenue growth driven by increased sales of LDDs and LALs.
RxSight, Inc. reported a strong fourth quarter with a 91% increase in revenue compared to Q4 2021, driven by increased sales of Light Delivery Devices (LDDs) and Light Adjustable Lenses (LALs). The company's installed base of LDDs expanded significantly, and LAL procedure volumes more than tripled. The company provided revenue guidance for 2023 between $78.0 million and $83.0 million.
- Revenue increased by 91% compared to Q4 2021, reaching $16.1 million.
- Light Delivery Device (LDD) sales increased by 27%, with an installed base of 400 units at the end of the quarter.
- Light Adjustable Lens (LAL) sales increased by 208% in procedure volumes compared to Q4 2021.
- Net loss was $(15.6) million, or $(0.56) per basic and diluted share.
Headline financials
Revenue & EPS history
Rxsight · Revenue · Quarterly
$16.1M
Revenue by segment
Rxsight · $11.4M total across 2 segments · Q2 2022
- LAL Revenue$5.8M—50.9%
- LDD Revenue$5.6M—49.1%
Forward guidance
RxSight provided 2023 revenue guidance range of $78.0 million to $83.0 million, representing implied growth of 59% to 69% compared to 2022. Provided 2023 gross margin guidance range of 52% to 54%, representing an implied increase of 19% to 24% compared to 2022. Provided operating expense guidance range of $105.0 million to $108.0 million, representing an implied growth of 24% to 28% compared to 2022.
Tailwinds
- Revenue guidance range of $78.0 million to $83.0 million, representing implied growth of 59% to 69% compared to 2022.
- Gross margin guidance range of 52% to 54%, representing an implied increase of 19% to 24% compared to 2022.
Headwinds
- Operating expense guidance range of $105.0 million to $108.0 million, representing an implied growth of 24% to 28% compared to 2022.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q4 2022
-1.1%
Avg return
Earnings day
-2.6%
Avg return
5 days after
+2.8%
Avg return
30 days after
45%
9 / 20 earnings
Positive
+15.1%
Q3 2022
Best reaction
-16.1%
Q2 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -6.6% | -21.6% | -31.1% | |
| Q4 2025 | -10.1% | -13.5% | -28.9% | |
| Q3 2025 | +8.7% | +16.3% | +46.7% | |
| Q1 2025 | -11.2% | -11.4% | +0.9% | |
| Q4 2024 | -0.8% | -7.8% | -9.1% | |
| Q3 2024 | -12.3% | -16.9% | -21.2% | |
| Q2 2024 | +14.6% | +21.5% | +29.0% | |
| Q1 2024 | +0.8% | -3.8% | -5.0% | |
| Q4 2023 | -5.8% | -3.2% | -10.9% | |
| Q3 2023 | +1.8% | +9.5% | +40.8% | |
| Q2 2023 | -1.5% | -6.3% | -1.8% | |
| Q1 2023 | +9.0% | +18.3% | +34.0% | |
| Q4 2022 | +9.7% | +4.5% | +17.9% | |
| Q3 2022 | +15.1% | +14.6% | +18.1% | |
| Q2 2022 | -2.9% | -8.3% | -13.3% | |
| Q1 2022 | -4.3% | -3.0% | +34.9% | |
| Q4 2021 | +1.4% | -3.2% | +1.8% | |
| Q3 2021 | +3.7% | -0.8% | -4.0% | |
| Q4 2020 | -16.1% | -18.4% | -21.1% | |
| Q2 2021 | -16.1% | -18.4% | -21.1% | |
| Q1 2021 | — | — | — | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro